The Cooper Companies' Women's Healthcare Unit Acquires EndoSee

The Cooper Companies, Inc. (NYSE: COO) today announced that CooperSurgical, its women's healthcare unit, has acquired EndoSee Corporation, a developer of an office-based disposable hysteroscopy system. The transaction is valued at approximately $44 million and is expected to be neutral to fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.

Commenting on the transaction, Robert S. Weiss, Cooper's president and chief executive officer, said, "The acquisition of EndoSee fits perfectly with CooperSurgical's office/surgical strategy of bringing high quality products to the OB/GYN while leveraging our infrastructure. This product has been cleared by the FDA and we plan to launch the product in the U.S. in the middle of fiscal 2015."